|
Urinary tract infection
|
0.070 |
Biomarker
|
group |
BEFREE |
Carbapenem-Resistant KPC- and TEM-Producing <i>Escherichia coli</i> ST131 Isolated from a Hospitalized Patient with Urinary Tract Infection: First Isolation in Molise Region, Central Italy, July 2018.
|
31386590 |
2020 |
|
Obesity
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
Hence, these results suggest that TNMD genetic variants could be potentially useful as early life risk indicators for obesity and T2DM.
|
30850679 |
2019 |
|
Urinary tract infection
|
0.070 |
Biomarker
|
group |
BEFREE |
One hundred and fifty-one <i>E. coli</i> isolates from bacteremia and UTI in children were screened for CTX-M, TEM, SHV and OXA β-lactamases by polymerase chain reaction and sequencing.
|
30013375 |
2018 |
|
Urinary tract infection
|
0.070 |
Biomarker
|
group |
BEFREE |
The present study was aimed to detect the prevalence of TEM and CTX-M type genes from GNB on urinary tract infection (UTIs).
|
29778819 |
2018 |
|
Urinary tract infection
|
0.070 |
Biomarker
|
group |
BEFREE |
Prevalence of TEM, SHV, and CTX-M genes of extended-spectrum β-lactamase-producing Escherichia coli strains isolated from urinary tract infections in adults.
|
28710743 |
2017 |
|
Urinary tract infection
|
0.070 |
Biomarker
|
group |
BEFREE |
Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections.
|
28193648 |
2017 |
|
Obesity
|
0.070 |
Biomarker
|
disease |
BEFREE |
Our data suggest that TNMD acts as a protective factor in visceral adipose tissue to alleviate insulin resistance in obesity.
|
26880110 |
2016 |
|
Urinary tract infection
|
0.070 |
Biomarker
|
group |
BEFREE |
We, therefore, determined the prevalence and co-resistance of PA and non-PA ESBL-E. coli in community-acquired and nosocomial urinary tract infections in humans and bla CTX-M-1 and bla TEM-52 isolates from poultry.
|
23519865 |
2013 |
|
Obesity
|
0.070 |
Biomarker
|
disease |
BEFREE |
In this review, the potential mechanisms that could link TNMD with the pathogenesis of obesity and related disorders are discussed.
|
20429799 |
2010 |
|
Obesity
|
0.070 |
AlteredExpression
|
disease |
BEFREE |
The aim of this study was to investigate TNMD tissue distribution and TNMD gene expression in human adipose tissue in relation to obesity and metabolic disease.
|
19602561 |
2009 |
|
Obesity
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
We have reported that the sequence variation in the tenomodulin (TNMD) gene is associated with the risk of type 2 diabetes (T2DM), central obesity and serum levels of systemic immune mediators in the Finnish Diabetes Prevention Study (DPS), which is a longitudinal lifestyle intervention study on 522 middle-aged persons with impaired glucose tolerance (IGT).
|
18982016 |
2008 |
|
Obesity
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
We have reported that the genetic variation of the tenomodulin gene (TNMD) is associated with the risk of type 2 diabetes (T2DM), central obesity, and impaired glucose metabolism and the TNMD mRNA levels correlate with serum and mRNA levels of inflammatory markers.
|
18580688 |
2008 |
|
Obesity
|
0.070 |
Biomarker
|
disease |
BEFREE |
Tenomodulin is associated with obesity and diabetes risk: the Finnish diabetes prevention study.
|
17495183 |
2007 |
|
Urinary tract infection
|
0.070 |
Biomarker
|
group |
BEFREE |
During a previous survey, five extended-spectrum beta-lactamase (ESBL)-producing enterobacteria (ESBLE) (two Enterobacter aerogenes isolates expressing TEM-24 b, two Escherichia coli isolates expressing TEM-21 or TEM-24 b, and one Klebsiella pneumoniae isolate expressing SHV-4/TEM-15) responsible for urinary tract infections (UTIs) were found among 1,584 strains collected from community patients.
|
16207960 |
2005 |
|
Neoplasms
|
0.060 |
Biomarker
|
group |
BEFREE |
We adopted three different methods: TEM, NTA and western blot analysis to characterize the cell-derived exosomes from NCI-H69 SCLC cell line and normal bronchial epithelial BEAS-2B cell line. we next explored the effects of these exosomes on HUVE cell proliferation and migration in vitro.To verify sFlt-1-loaded exosomes suppress the tumor growth in vivo,we established subcutaneous xenografts in nude mice using the NCI-H69 cell line.
|
31441580 |
2019 |
|
Neoplasms
|
0.060 |
Biomarker
|
group |
BEFREE |
For this, we explored the tumor microenvironment for targeted drug delivery and synthesized (temperature and pH responsive) double triggered polymeric nanoparticles by the free radical mechanism and characterized them by DLS and TEM.
|
31549130 |
2019 |
|
Neoplasms
|
0.060 |
Biomarker
|
group |
BEFREE |
The sequential delivery vesicles showed the anticipated three-layered TEM structure and dual-convertible (surface charge- and particle size-reversible) features in the tumor environment (pH 6.5), which guaranteed the sequential release of siVEGF-CPPs and PTX in the tumor extracellular environment and tumor cells, respectively.
|
30144476 |
2018 |
|
Neoplasms
|
0.060 |
Biomarker
|
group |
BEFREE |
Interestingly, TEM images of tumor sections show intercellular lysosomal subcellular localization of the GNP-ABPs.
|
30148621 |
2018 |
|
Neoplasms
|
0.060 |
Biomarker
|
group |
BEFREE |
Our recent work has shown that breast cancer cell adhesion to vascular endothelial cells activates endothelial MMP-2, promoting tumor cell transendothelial migration (TEM(E)).
|
20571065 |
2010 |
|
Neoplasms
|
0.060 |
Biomarker
|
group |
BEFREE |
Furthermore, the transduction of either Ad-shTeM or Ad-shChM-I in human melanoma cells resulted in suppression of tumor growth in association with decreased vessel density in vivo.
|
15150318 |
2004 |
|
Transmissible mink encephalopathy
|
0.050 |
Biomarker
|
disease |
BEFREE |
The surface morphology, crystal structure, functional groups, elemental composition, and optical properties of the Si-CQDs were characterized using TEM (HRTEM), XRD, FT-IR, XPS, UV-vis absorption and fluorescence spectroscopy.
|
31280375 |
2019 |
|
Transmissible mink encephalopathy
|
0.050 |
Biomarker
|
disease |
BEFREE |
Using 30keV, which is lower than that for conventional TEM (100-300keV), together with low detection angles (15-55mrad) enhances the signals from the fibrils.
|
28267641 |
2017 |
|
Transmissible mink encephalopathy
|
0.050 |
Biomarker
|
disease |
BEFREE |
The structure, morphology, and optical properties of the as-prepared WS<sub>2</sub>/Bi<sub>2</sub>MoO<sub>6</sub> samples were characterized by XRD, XPS, SEM, TEM (HRTEM), and UV-vis diffuse reflectance spectra (DRS).
|
28565885 |
2017 |
|
Transmissible mink encephalopathy
|
0.050 |
Biomarker
|
disease |
BEFREE |
Isolates were screened for the presence of the β-lactamase-TEM (BlaTEM) and β-lactamase-cfxA genes using Polymerase Chain Reaction (PCR).
|
27119762 |
2016 |
|
Transmissible mink encephalopathy
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Three isolates harbored both bla(TEM-34(IRT-6)) and bla(CTX-M-15). bla(SHV-12) was identified either alone or with bla(CTX-M-15) in a single isolate.
|
21288137 |
2011 |